α-Rhamnosyl FP20 A86781 (Previously 860781) 6-O-α-D-Rhamnopyranosyl-1ß,2N,3-tridodecanoyl-D-glucosamine-4-phosphate, sodium salt
FP-20 offers another innovative approach to boosting vaccine efficacy by selectively stimulating Toll-like receptor 4 (TLR4) pathways. The simplicity of FP structures allows for scalable production of highly pure materials, ensuring a reliable and cost-effective supply for vaccine developers. Like VSA, FP adjuvants provide both humoral and cellular immune enhancements but achieve this through a targeted, mechanism-driven approach.
